Validity and Reliability of CTQ-SSS in Carpal Tunnel Syndrome.

Carpal Tunnel Syndrome Clinical Trial

Official title:

Validity and Reliability of the Shorter Version of the CTQ-SSS in Patients With Carpal Tunnel Syndrome: A Cross-sectional Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05838976
• Other study ID #: 012/00X0021
• Status: Recruiting
• Start date: May 2023
• Est. completion date: October 2023

Study information

• Verified date: April 2023
• Source: Ahram Canadian University
• Contact: Mohamed M ElMeligie
• Phone: +201064442032
• Email: mohamed.elmeligie[@]acu.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To determine the validity and reliability of the shorter version of the CTQ-SSS in patients with carpal tunnel syndrome (CTS) undergoing nonsurgical management.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: October 2023
• Est. primary completion date: September 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Patients diagnosed with carpal tunnel syndrome based on clinical presentation and/or nerve conduction studies.

• Patients aged 18 years to 60 years old.

• Patients who are undergoing nonsurgical management for carpal tunnel syndrome.

Exclusion Criteria:

• Patients with a history of hand or wrist surgery within the past 6 months.

• Patients with severe hand or wrist pain that would prevent completion of the outcome measures or interfere with their ability to participate in the study.

• Patients with severe cognitive impairment or language barrier that would prevent understanding of the study instructions or interfere with their ability to participate in the study.

• Patients with any other medical condition that could affect hand function or interfere with test completion.

Related Conditions & MeSH terms

• Carpal Tunnel Syndrome
• Syndrome

Intervention

Diagnostic Test:
• Shorter Version of the CTQ-SSS
The intervention in this study is the administration of the shorter version of the CTQ-SSS, a validated questionnaire designed to assess the severity of symptoms and functional limitations associated with carpal tunnel syndrome. The CTQ-SSS consists of 8 items related to symptom severity and 2 items related to functional status. The scores for each set of items are combined to generate symptom severity and functional status scores, which will be used to assess the validity and reliability of the CTQ-SSS in patients with carpal tunnel syndrome undergoing nonsurgical management.

Locations

Country	Name	City	State
Egypt	Outpatient clinic of faculty of physical therapy, Ahram Canadian University	Al ?ayy Ath Thamin	Giza

Sponsors (1)

Lead Sponsor	Collaborator
Ahram Canadian University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Validity and Reliability of the Shorter Version of the CTQ-SSS	To determine the validity and reliability of the shorter version of the CTQ-SSS in patients with carpal tunnel syndrome undergoing nonsurgical management. The CTQ-SSS will be administered at baseline and at a follow-up visit within 2-4 weeks to assess test-retest reliability. Internal consistency will be assessed using Cronbach's alpha coefficient. Construct validity will be assessed by comparing the CTQ-SSS scores with other functional measures such as the DASH questionnaire and PRWE using Pearson's correlation coefficient.	Outcome measures will be assessed within 2-4 weeks of the initial CTQ-SSS administration.